In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex
- PMID: 2817858
- PMCID: PMC172713
- DOI: 10.1128/AAC.33.9.1614
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex
Abstract
The in vitro activities of 12 macrolide compounds against 28 Mycobacterium avium complex strains isolated from patients with acquired immunodeficiency syndrome were determined by the conventional proportion method and by the BACTEC method. Clarithromycin (A-56268; TE-031), a new macrolide compound, was the most active agent tested, inhibiting 90% of strains at an MIC of 4 micrograms/ml by the BACTEC method. Roxithromycin (RU 28965) and erythromycylamine inhibited 90% of strains at 16 micrograms/ml. The organisms showed high levels of resistance to most other macrolide compounds.
Similar articles
-
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.Antimicrob Agents Chemother. 1990 Aug;34(8):1508-11. doi: 10.1128/AAC.34.8.1508. Antimicrob Agents Chemother. 1990. PMID: 2171421 Free PMC article.
-
In vitro and in vivo activities of clarithromycin against Mycobacterium avium.Antimicrob Agents Chemother. 1989 Sep;33(9):1531-4. doi: 10.1128/AAC.33.9.1531. Antimicrob Agents Chemother. 1989. PMID: 2530933 Free PMC article.
-
Comparison of in vitro antimicrobial susceptibilities of Mycobacterium avium-M. intracellulare strains from patients with acquired immunodeficiency syndrome (AIDS), patients without AIDS, and animal sources.Antimicrob Agents Chemother. 1990 Jul;34(7):1390-2. doi: 10.1128/AAC.34.7.1390. Antimicrob Agents Chemother. 1990. PMID: 2386370 Free PMC article.
-
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?Res Microbiol. 1992 May;143(4):411-9. doi: 10.1016/0923-2508(92)90055-s. Res Microbiol. 1992. PMID: 1455069 Review. No abstract available.
-
Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.Res Microbiol. 1994 Mar-Apr;145(3):188-96. doi: 10.1016/0923-2508(94)90017-5. Res Microbiol. 1994. PMID: 7809471 Review. No abstract available.
Cited by
-
Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.Antimicrob Agents Chemother. 1990 Aug;34(8):1508-11. doi: 10.1128/AAC.34.8.1508. Antimicrob Agents Chemother. 1990. PMID: 2171421 Free PMC article.
-
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.Antimicrob Agents Chemother. 1992 Sep;36(9):1987-90. doi: 10.1128/AAC.36.9.1987. Antimicrob Agents Chemother. 1992. PMID: 1416891 Free PMC article.
-
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.Drug Saf. 1999 Jan;20(1):25-41. doi: 10.2165/00002018-199920010-00004. Drug Saf. 1999. PMID: 9935275 Review.
-
Quantitative lipid composition of cell envelopes of Corynebacterium glutamicum elucidated through reverse micelle extraction.Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15360-5. doi: 10.1073/pnas.1112572108. Epub 2011 Aug 29. Proc Natl Acad Sci U S A. 2011. PMID: 21876124 Free PMC article.
-
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice.Antimicrob Agents Chemother. 1994 Jul;38(7):1452-4. doi: 10.1128/AAC.38.7.1452. Antimicrob Agents Chemother. 1994. PMID: 7979270 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical